occurs in has participant quality has disease treated with drug INTERFERON ALFA-2A VENLAFAXINE HYDROXYUREA INDOMETHACIN SULFASALAZINE PENICILLAMINE AMIODARONE HYDROCHLORIDE CYTARABINE RIBAVIRIN ZIDOVUDINE MITOXANTRONE HYDROCHLORIDE BUPROPION CLOMIPRAMINE DESIPRAMINE DOXORUBICIN FLUOXETINE GANCICLOVIR PAROXETINE RITONAVIR DOCETAXEL TOPIRAMATE TOLCAPONE CAPECITABINE TRASTUZUMAB BEXAROTENE RIVASTIGMINE ZONISAMIDE PEGINTERFERON ALFA-2B IMATINIB BORTEZOMIB PEMETREXED TINIDAZOLE ERLOTINIB SORAFENIB CABAZITAXEL mature T-cell and NK-cell lymphoma EAST syndrome Cytomegalovirus retinitis heart conduction disease prostate cancer obsessive-compulsive disorder bulimia nervosa lymphocytic choriomeningitis dementia generalized anxiety disorder Parkinson's disease major depressive disorder mental depression breast cancer cancer pancreatic cancer epilepsy hepatitis C trichomoniasis anxiety disorder post-traumatic stress disorder ovarian cancer hairy cell leukemia bipolar disorder bacterial vaginosis dermatofibrosarcoma protuberans non-small cell lung carcinoma human immunodeficiency virus infectious disease panic disorder hepatocellular carcinoma rheumatoid arthritis chronic myeloid leukemia ulcerative colitis Wilson disease amebiasis gastrointestinal stromal tumor colorectal cancer multiple myeloma Elderly Child Adult Adolescent anorexia AE 10002646 10002649 10061428 YH, MW decreased appetite AE WEB: http://www.mayoclinic.org/diseases-conditions/anorexia/basics/definition/con-20033002 SIDER: C0003123 NCIt: C2875 HPO: HP_0002039 a gustatory system AE which demonstrates a decreased sensation of appetite. anorexia nervosa AE CTCAE: E12252 厌食症 gustatory system AE AE severity G1 AE severity G2 AE severity G3 AE severity G4 AE severity G5